Debrief
发表于 2025-3-25 06:53:23
http://reply.papertrans.cn/20/1906/190575/190575_21.png
货物
发表于 2025-3-25 08:39:37
Hans-Peter Roth,Manfred Kirchgessnerexplores the systemic effects of chemotherapy on ovarian function, and fertility sparing measures available to women. Overall, the evidence in the literature suggests that subsequent pregnancy does not appear to adversely effect long-term breast cancer outcomes.
伦理学
发表于 2025-3-25 12:26:15
https://doi.org/10.1007/978-1-137-11183-8ent of cardiotoxicity secondary to Anthracyclines, Trastuzumab and radiotherapy, in breast cancer patients. Approaches to risk stratification, surveillance, prevention and treatment of cardiotoxicity in these patients will also be discussed.
开玩笑
发表于 2025-3-25 15:58:46
https://doi.org/10.1007/978-3-540-78572-9 of ovarian cancer will be considered and what measures can be taken to reduce these risks..Finally we will also consider family issues related to germline mutations including fertility and preimplantation genetic diagnosis and cascade testing.
容易做
发表于 2025-3-25 22:04:13
http://reply.papertrans.cn/20/1906/190575/190575_25.png
Euphonious
发表于 2025-3-26 03:15:13
Follow Up of Patients with Germline Mutations in High Risk Predisposition Genes of ovarian cancer will be considered and what measures can be taken to reduce these risks..Finally we will also consider family issues related to germline mutations including fertility and preimplantation genetic diagnosis and cascade testing.
CODE
发表于 2025-3-26 08:08:47
http://reply.papertrans.cn/20/1906/190575/190575_27.png
为现场
发表于 2025-3-26 10:30:58
http://reply.papertrans.cn/20/1906/190575/190575_28.png
larder
发表于 2025-3-26 12:39:32
Fertilityexplores the systemic effects of chemotherapy on ovarian function, and fertility sparing measures available to women. Overall, the evidence in the literature suggests that subsequent pregnancy does not appear to adversely effect long-term breast cancer outcomes.
带来
发表于 2025-3-26 20:39:31
Cardiotoxicity in Breast Cancer Survivorsent of cardiotoxicity secondary to Anthracyclines, Trastuzumab and radiotherapy, in breast cancer patients. Approaches to risk stratification, surveillance, prevention and treatment of cardiotoxicity in these patients will also be discussed.